🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very helpful guide (How I treat: quantitative fibrinogen disorders) including pregnancy and perioperatively!) Interesting real world cases! doi.org/10.1182/blood.…

Reassuringly in major thrombophilia including AT deficiency (where arms were quite balanced) reduced dose DOAC seems to be a better option. Another reason not to test for thrombophilia!

The Repeat Study addressed a really important knowledge gap! The incidence of recurrent events following an ante- or postpartum VTE is 2.4% person-years. The cumulative risks are 6%, 13%, 17%, and 30% at 2, 5, 10, and 30 years respectively. jthjournal.org/article/S1538-…

Registration is now live for our next webinar on 25th March with Prof Saskia Middeldorp and Dr Giulia Simini, in collaboration with @thelimbichaemUK thelimbic.com/uk/haematology… 'Thrombosis, thrombophilia and pregnancy – a tale of patience and persistence'

A reminder that HaemSTAR can offer travel grants to support trainees and allied health professionals to attend meetings and conferences etc. Our next review of applications is in June. See our website for details: haemstar.org/travel-grants

Excited to share an important new document from Anticoagulation Forum and FWGBD addressing the care of folks with the potential to menstruate (or enter menopause!) or become pregnant. Check it out! acforum.org/web/resource_f…

Prof. Mahé Isabelle presents API-CAT at #ACC2025, published in NEJM Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in patients with cancer. nejm.org/doi/full/10.10…

Now up on all podcast platforms! Pip Nicolson and I review the programme for non-malignant haematology at BSH - Haematology 2025. Some great speakers but lots of horrible clashes. We'll be set up and recording at the HaemSTAR 💙 stand. Come say hi & you might end up on the show!

The much used RoyalCollegeObsGyn Greentop guideline 37a is being revised. Here is a BJOG commentary from Laura A Magee and the guideline update committee. In the journal doi.org/10.1111/1471-0… and on video vimeo.com/1072760896

Absolutely fantastic meeting and very educational! I enjoyed every session. Thanks so much for the organisers.

New - a film resource discussing and answering frequently asked questions about the physical impact and long-term considerations for women after a diagnosis of a blood clot. youtu.be/X9C-yXpDyq4?si… #LetsTalkClots #ThinkThrombosis #VTEMatters #bloodclots #women #PE #DVT

🚨 New podcast release! Blood shortages and major incident planning; Helen asks Suzy what the current situation is with blood stocks and what the role of the #haemSpR is open.spotify.com/episode/7EeHEV… podcasts.apple.com/gb/podcast/blo…

🆕article on Managing #anticoagulation 💊in #athletes and #sportspeople 🏃‍♀️🏃‍♂️ ➡️tinyurl.com/3vhxwsar 👀Read our 💬interview with 🖊️authors Elena Campello and Pablo Bucciarelli linkedin.com/pulse/managing…

1/ Out now in HemaSphere Journal (IF = 14.6). Interesting authorship this - consisting of some academic physicians, Chair of Sickle Cell Society and a fantastic patient advocate. We discuss the impact of recent approvals and reversals in sickle on the community. A short🧵 #OpenAccess